Prime Medicine Inc. (PRME) Social Stream
PRIME MEDICINE INC (PRME) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRME.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PRME Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PRIME MEDICINE INC's number of analysts covering the stock is higher than 47.94% of them.
- PRIME MEDICINE INC's variance in analysts' estimates is lower than 74.42% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, PRIME MEDICINE INC's upside potential (average analyst target price relative to current price) is greater than 51.1% of them.
- In terms of how PRIME MEDICINE INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 122.3% of that group.
What is the outlook for PRME? Use POWR Ratings for clearer insight into price direction.